平成 25 年（2013 年）発表論文
和文

1. 芹川武大, 南川高廣, 五日市美奈, 山田京子, 臼田東平, 榎本隆之, 高桑好一
胎児胸腔羊水腔シャントチューブ留置術が有効であった、胎児胸水を伴った13q-症候群の１例
日本遺伝カウンセリング学会誌 2013;34(1):49-52

2.石田真奈子, 芹川武大, 大木泉, 高桑好一, 田中憲一
周産期に発症したposterior reversible encephalopathy syndrome （PRES）６症例の臨床的検討
周産期医学 2013;43(5): 2013-2015

3. 小木幹奈, 山口雅幸, 上村直美, 吉田邦彦, 山田京子, 芹川武大, 榎本隆之, 高桑好一
本態性血小板血症合併妊娠の２症例
新潟産科婦人科学会会誌 2013;108(1):24-27

4. 竹越公美, 芹川武大, 高桑好一, 榊原清一, 和田雅樹
当院における新生児早発型GBS感染症予防対策
新潟産科婦人科学会会誌 2013;108(1):29-33

5. 高桑好一, 高橋真紀子, 吉田邦彦, 能仲太郎, 生野寿史, 芹川武大, 榎本隆之
血栓・止血の異常と妊娠 12.妊娠時のアスピリン療法

産科と婦人科 2013;80: 85-90

6. 上田豊, 榎本隆之, 木村正【子宮体がん診療アップデート】治療のトピックス 進行・再発子宮体がんの治療（解説／特集）
臨床婦人科産科 2013;67(59):505-10

7. 榎本隆之、吉野 潔
広汎子宮頸部摘出術：妊娠中も可能か?
OGS NOW 婦人科がん手術こんなときどうする？がんの根治とQOLの改善を目指して 2013;14:54-63

英文
1. Itsukaichi M, Takakuwa K, Yamaguchi M, Serikawa T, Tanaka K, Kojima K, Sakakibara S, Usuda T, Matsunaga M, Hashimoto T.
Twins with neonatal pemphigus vulgaris born to a mother with pemphigus vulgaris: a case report.
Pediatr Dermatol. 2013;30(4):e59-60.

2. Miyatake T, Ueda Y, Morimoto A, Enomoto T, Nishida S, Shirakata T, Oka Y, Tsuboi A, Oji Y, Hosen N, Nakatsuka S, Morita S,Sakamoto J, Sugiyama H, Kimura T.
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
J Cancer Res Clin Oncol. 2013 Mar;139(3):457-63.

3. Takehiro Serikawa, Keisuke Honda, Mina Itsukaichi, Kyoko Yamada, Koichi TakakuwaA Case of Trisomy 9 Complicated With Congenital Diaphragmatic Hernia
J Med Cases 2013;4(4):215-217

4. Miyatake T, Ueda Y, Morimoto A, Enomoto T, Nishida S, Shirakata T, Oka Y, Tsuboi A, Oji Y, Hosen N, Nakatsuka S, Morita S,Sakamoto J, Sugiyama H, Kimura T.
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
J Cancer Res Clin Oncol. 2013;139(3):457-63.

5. Hiramatsu K, Ueda Y, Yoshino K, Fujita M, Morii E, Enomoto T, Kimura T.
Conization using the Shimodaira-Taniguchi procedure for adenocarcinoma in situ of the uterine cervix.
Eur J Obstet Gynecol Reprod Biol. 2013;168(2):218-21.

6. Yokoyama T, Yoshino K, Ueda Y, Enomoto T.
Association between Endometriosis and Ovarian Cancer: A Review of Epidemiologic, Pathologic, Genetic, and Clinical Data,
Endometriosis: Risk Factors Symptoms and Management.
Pub. Date 2013-3rd Quarter

7. Ueda Y, Enomoto T, Matsuzaki S, Kobayashi E, Kimura T, Yoshino K, Fujita M, Tsutsui T, Kimura T.
Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin.
Cancer Chemother Pharmacol. 2013;71(6):1411-6.

8. Ueda Y, Miyatake T, Nagamatsu M, Yamasaki M, Nishio Y, Yoshino K, Fujita M, Tsutsui T, Enomoto T, Kimura T.
A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas(GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study).
Eur J Obstet Gynecol Reprod Biol. 2013;170(1):259-63.

9. Yoshino K, Enomoto T, Fujita M, Ueda Y, Kimura T, Kobayashi E, Tsutsui T, Kimura T.
Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20patients.
Int J Clin Oncol. 2013;18(1):148-53.

10. Yokoyama T, Enomoto T, Serada S, Morimoto A, Matsuzaki S, Ueda Y, Yoshino K, Fujita M, Kyo S, Iwahori K, Fujimoto M, Kimura T,Naka T.
Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
Int J Cancer. 2013;132(2):472-84.

11. Ugaki H, Komoto Y, Kakubari R, Tanaka E, Konishi H, Kitai T, Nakajima S, Muraji M, Enomoto T, Takemura M
Efficacy of Para-Aortic Lymphadenectomy in Ovarian Cancer: A Retrospective Study
Journal of cancer Therapy 2013;4(5A)28-32

12. Banzai C, Nishino K, Quan J, Yoshihara K, Sekine M, Yahata T, Tanaka K; Gynecological Cancer Registry of Niigata.
Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.

Int J Clin Oncol. 2014;19(1):127-32.

13. Serikawa T, Takakuwa K, Enomoto T
Management of patients with pregnancy-associated ovarian clear cell carcinoma: a mini-review.
Gynecol Obstet 2013;3:159

14. Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, CarterSL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG.
Inferring tumour purity and stromal and immune cell admixture from expression data.
Nat Commun. 2013;4:2612.

15. Yang JY, Yoshihara K, Tanaka K, Hatae M, Masuzaki H, Itamochi H; Cancer Genome Atlas (TCGA) Research Network, Takano M,
Ushijima K, Tanyi JL, Coukos G, Lu Y, Mills GB, Verhaak RG.
Predicting time to ovarian carcinoma recurrence using protein markers.
J Clin Invest. 2013 3;123(9):3740-50.

16. Hata Y, Nakaoka H, Yoshihara K, Adachi S, Haino K, Yamaguchi M, Nishikawa N, Kashima K, Yahata T, Tajima A, Watanabe A,Akira S, Hosomichi K, Inoue I, Tanaka K.
A nonsynonymous variant of IL1A is associated with endometriosis in Japanese population.
J Hum Genet. 2013;58(8):517-20.

17. Yamaguchi M, Yoshida K, Takano T, Enomoto T, Takakuwa K.
Placenta previa and percreta with massive genital bleeding in the first trimester of pregnancy: A case report
Open Journal of Obstetrics and Gynecology 2013;3(9):690-693

18. Hori M, Kim T, Onishi H, Imaoka I, Kagawa Y, Murakami T, Nakamoto A, Ueguchi T, Tatsumi M, Enomoto T, Kimura T, Tomiyama
N.
Endometrial cancer: preoperative staging using three-dimensional T2-weighted turbo spin-echo and diffusion-weighted MR imaging at
3.0 T: a prospective comparative study.
Eur Radiol. 2013;23(8):2296-305.

19. Kashima K, Yahata T, Yamaguchi M, Fujita K, Tanaka K.
Ovarian pregnancy resulting from cryopreserved blastocyst transfer.
J Obstet Gynaecol Res. 2013;39(1):375-7.

20. Kashima K, Yahata T, Fujita K, Tanaka K.
Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer.
Int J Gynaecol Obstet. 2013;121(1):53-5.

21. Adachi S, Enomoto T.
Molecular Biology of Endometriosis
Endometriosis: Risk Factors, Symptoms and Management 2013;269-274

・Matsuzaki S, Enomoto T, Serada S, Yoshino K, Nagamori S, Morimoto A, Yokoyama T, Kim A, Kimura T, Ueda Y, Fujita M, Fujimoto M,Kanai Y, Kimura T, Naka T.
Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.
Int J Cancer. 2014;134(8):1796-809.